Remove Clinical Trials Remove FDA Compliance Remove Life Science
article thumbnail

FDA Refines Accelerated Approval Pathway with New Draft Guidance

XTalks

This shift not only prioritizes patient safety but also ensures that ineffective treatments are identified more quickly.

article thumbnail

How FDA’s AI Draft Guidance Aims to Bring Transparency to Drug Development

XTalks

Last year, Sanofi partnered with Formation Bio and OpenAI to introduce Muse, an AI-powered tool designed to accelerate patient recruitment for clinical trials. The possibilities of applying AI in drug development are vast and varied.